Biofrontera Files sNDA to Broaden Ameluz PDT Label for Actinic Keratoses
Biofrontera has submitted an sNDA to the FDA seeking approval of Ameluz PDT for actinic keratoses on body areas beyond its currently labeled treatment sites.
Topic
Snda
Topic
Topic
Topic
Biofrontera has submitted an sNDA to the FDA seeking approval of Ameluz PDT for actinic keratoses on body areas beyond its currently labeled treatment sites.